Study finds stress-related nerves may fuel pancreatic cancer growth
New research from OHSU points to an unexpected player in cancer research: nerves.
Research
More Research Stories
- Latest Stories
Prenatal care delivers multigenerational benefits
October 11, 2017
Expanding prenatal care to unauthorized immigrant women in Oregon reduced death rates for U.S. born infants and helped prevent disease and complications for both women and their children.
Internationally renowned scientist Gordon B. Mills recruited to lead precision oncology for the OHSU Knight Cancer Institute
October 10, 2017
One of the most highly cited medical scientists in the world, Mills brings a breadth of research, leadership experience to OHSU.
OHSU, ORPRN receive $8 million to help people with serious illnesses get the care they want
October 05, 2017
A collaboration with U.S. and Canadian-based networks of primary care practices, study will compare impacts of clinician-focused and team-based approaches to advance care planning.
Direct reminder reduces missed appointments, study shows
October 04, 2017
A new study reveals that directly connecting with patients by phone makes a major difference in reducing the number of no-shows.
OHSU to pioneer digital health innovation for the benefit of patients nationwide
October 03, 2017
OHSU has been awarded two grants totaling $62 million from the National Center for Advancing Translational Sciences, to help bridge basic science and clinical research.
New NIH-funded research hub focuses on emergency care
September 27, 2017
OHSU emergency department participating in a nationwide clinical trial.
Drug improves heart's pumping efficiency
September 27, 2017
Review committee has no safety concerns following a Phase II trial of a drug used to treat hypertrophic cardiomyopathy.
Translational research institute at OHSU receives $37 million
September 26, 2017
The Oregon Clinical & Translational Research Institute at OHSU has received a $37 million boost from the federal government to help accelerate the translation of research into clinical use, medical practice and health policy.
OHSU Doernbecher is first hospital in Pacific Northwest to offer new FDA-approved treatment for advanced leukemia
September 21, 2017
The first FDA-approved gene transfer therapy for patients with acute lymphoblastic leukemia will be available at a handful of approved hospitals, including OHSU Doernbecher.
Oral antibiotics after C-section may reduce infection risk for obese women
September 20, 2017
JAMA study showed obese women who delivered via cesarean had reduced surgical-site infection rates when they received oral antibiotics post-delivery.